This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
Leveraged Small-Cap and Inverse Leveraged Gold Miners: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
URTY and JDST have seen elevated trading volume on Wednesday.
Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FLQL
Inverse Leveraged Brazil and Gold Miners: 2 ETFs to Watch on Outsized Volume
by Sanghamitra Saha
BZQ and DUST have seen elevated trading volume on Friday.
Are The Equity Markets Over Optimistic?
by Daniel Laboe
The global economy has been put into a medically induced coma, with the pandemic forcing economies around the world to pause
Should Invesco Russell 1000 Equal Weight ETF (EQAL) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EQAL
6 Top-Ranked ETFs Beating the Market
by Sweta Killa
With the start of the second quarter, the U.S. stock markets have regained momentum on easing coronavirus pandemic as well as unprecedented fiscal and monetary stimulus.
Zacks Investment Ideas feature highlights: SPY, Microsoft, Alibaba, Adobe and Nvidia
by Zacks Equity Research
Zacks Investment Ideas feature highlights: SPY, Microsoft, Alibaba, Adobe and Nvidia
Markets Up on COVID-19 Treatment Data
by Mark Vickery
Remsdesivir, a daily infusion treatment from Gilead Sciences (GILD) that has so far shown positive results in a phase-3 study at the University of Chicago Medicine.
How To Navigate The Choppy Markets
by Daniel Laboe
22 million filed for unemployment in the past month, the SBA fund ran dry, pandemic case count tops 2 million, and it will likely be months before the economy is able to safely open up. So, is the S&P 500's 28% recovery justified?